Top 10: Medical Equipment Manufacturers

Medical technology manufacturers play a vital role in modern healthcare, developing the equipment, devices and technologies that support diagnosis, treatment and patient care. 

From advanced imaging systems and surgical robotics to cardiovascular implants and minimally invasive instruments, the sector continues to evolve through innovation and investment. 

As demand for more efficient, precise and connected healthcare grows, manufacturers are expanding their portfolios and advancing new technologies. 

In this Top 10, Healthcare Digital explores the world's largest medical equipment manufacturers, ranked by reported annual revenue in 2025, and examines their product portfolios, manufacturing activities and key developments shaping the industry in 2026.

10. Intuitive Surgical

HQ: Sunnyvale, California

CEO: David Rosa

Revenue: US$10.06bn (2025)

Intuitive Surgical develops, manufactures and markets robotic-assisted surgical systems, including its flagship da Vinci platform and Ion endoluminal system for minimally invasive lung biopsies. 

Its latest-generation da Vinci 5 system gained FDA clearance for selected cardiac procedures in January 2026, while March approvals extended the lifespan of its Force Feedback instruments. 

In September 2026, the company secured European CE marking for the instruments, alongside more than 100 system enhancements. Its global da Vinci installed base exceeds 12,000 systems.

9. Boston Scientific

HQ: Marlborough, Massachusetts

CEO: Michael (Mike) Mahoney

Revenue: US$20.07bn (2025)

Boston Scientific is a US medical technology manufacturer specialising in devices for cardiovascular, urological, endoscopic and neurological procedures. 

Its portfolio includes the FARAPULSE pulsed field ablation system, WATCHMAN left atrial appendage closure devices and LithoVue single-use endoscopes.

In 2026, the company agreed to acquire vascular technology specialist Penumbra for approximately US$14.5bn, expanding its capabilities in mechanical thrombectomy and neurovascular treatments. It also received FDA clearance for its Asurys fluid management system for endoscopic urological procedures.

8. Philips

HQ: Amsterdam, Netherlands

CEO: Roy Jakobs

Revenue: €17.83bn (approximately US$20.2bn) (2025)

Philips, a Netherlands-headquartered health technology manufacturer, specialises in diagnostic imaging, ultrasound, image-guided therapy, patient monitoring and healthcare informatics. 

Its manufacturing portfolio includes MRI and CT scanners, ultrasound systems, interventional imaging equipment and patient monitoring devices. 

In April 2026, Philips received FDA clearance for Verida, its AI-powered spectral CT system, while its IntraSight Plus interventional cardiology platform launched in the US and Europe. The company also invested US$150m in expanding its US manufacturing and R&D capabilities.

7. GE HealthCare

HQ: Chicago, Illinois

CEO: Peter Arduini

Revenue: US$20.63bn (2025)

GE HealthCare manufactures medical imaging, diagnostic and patient monitoring equipment, supplying hospitals and healthcare providers worldwide. 

Its portfolio includes MRI and CT scanners, ultrasound systems, X-ray equipment, anaesthesia machines and molecular imaging technologies. 

In March 2026, the company received FDA clearance for Photonova Spectra and has since received a CE marking for its next-generation photon-counting CT system featuring proprietary Deep Silicon detector technology. It also secured clearance for three new MRI innovations, including its helium-efficient SIGNA Sprint and SIGNA Bolt scanners, strengthening its position in advanced diagnostic imaging.

6. Abbott (Medical Devices)

HQ: Abbott Park, Illinois

CEO: Robert B. Ford

Revenue: US$21.39bn (medical devices segment, 2025)

Abbott is a global healthcare manufacturer whose medical devices division produces technologies spanning cardiovascular care, diabetes management and neuromodulation. 

Its portfolio includes FreeStyle Libre continuous glucose monitoring systems, MitraClip heart valve repair devices, Aveir leadless pacemakers and electrophysiology equipment. 

In April 2026, Abbott received FDA clearance and European CE Mark for Ultreon 3.0, an AI-powered coronary imaging platform combining high-resolution optical coherence tomography with automated insights. Abbott also received FDA approval for its TactiFlex Duo catheter, which combines pulsed field and radiofrequency ablation.

5. BD (Becton, Dickinson and Company)

HQ: Franklin Lakes, New Jersey

CEO: Tom Polen

Revenue: US$21.84bn (2025)

BD (Becton, Dickinson and Company) is a global medical technology manufacturer producing medical devices, instrument systems and diagnostic products used across hospitals, laboratories and pharmaceutical manufacturing. 

Its portfolio includes injection and infusion systems, surgical instruments, vascular access devices and medication management technologies. 

In February 2026, BD completed the spin-off of its Biosciences and Diagnostic Solutions business into Waters Corporation, sharpening its focus on medical technology. BD also announced a US$3bn US manufacturing investment, aimed at expanding domestic production of essential medical products.

4. Stryker

HQ: Portage, Michigan

CEO: Kevin Lobo (to be succeeded by Spencer Stiles from 1 January 2027)

Revenue: US$25.12bn (2025)

Stryker is a US medical technology manufacturer specialising in orthopaedics, surgical equipment, neurotechnology and patient handling systems. 

Its portfolio includes joint replacement implants, Mako robotic-assisted surgery systems, hospital beds, surgical instruments and devices for treating stroke and vascular conditions. 

In May 2026, Stryker completed its acquisition of Amplitude Vascular Systems, adding next-generation intravascular lithotripsy technology to its peripheral vascular portfolio. It also launched the TPX HD power tool in June 2026, designed to support complex orthopaedic procedures and improve surgical precision.

3. Siemens Healthineers

HQ: Erlangen, Germany 

CEO: Dr Bernd Montag

Revenue: €23.38bn (approximately US$26.4bn) (FY2025)

Siemens Healthineers is a German medical technology manufacturer specialising in diagnostic imaging, laboratory diagnostics and cancer care. 

Its portfolio includes MRI and CT scanners, X-ray systems, ultrasound equipment, laboratory analysers and Varian radiotherapy technologies. 

In September 2026, the company opened a new semiconductor fabrication facility in Forchheim, Germany, dedicated to manufacturing sensors for its photon-counting CT scanners. The facility is the only one of its kind in Europe, strengthening Siemens Healthineers' control over a critical component of advanced medical imaging technology.

2. Medtronic

HQ: Galway, Ireland (principal executive office); Minneapolis, Minnesota (operational headquarters)

CEO: Geoff Martha

Revenue: US$33.54bn (FY2025)

Medtronic is a global medical technology manufacturer producing devices and equipment across cardiovascular care, neuroscience, surgical technologies and diabetes management. 

Its extensive portfolio includes pacemakers, defibrillators, heart valves, spinal implants, surgical instruments and robotic-assisted surgery systems. 

In March 2026, Medtronic received FDA approval for its OmniaSecure defibrillation lead, the first of its kind approved for conduction system pacing. The company also advanced its Hugo robotic-assisted surgery platform, submitting US regulatory applications to expand its use into general and gynaecological procedures. 

Its fiscal 2026 results, reported in June, showed revenue of US$36.4bn, up 8.4%, with continued investment in product innovation and manufacturing capabilities supporting its global medical technology business.

1. Johnson & Johnson MedTech

HQ: New Brunswick, New Jersey

CEO: Tim Schmid (Executive Vice President and Worldwide Chairman, MedTech)

Revenue: US$33.79bn (MedTech segment, 2025)

Johnson & Johnson MedTech is a global medical technology manufacturer producing devices and equipment across cardiovascular care, surgery, orthopaedics and vision. 

Its extensive portfolio includes electrophysiology systems, heart pumps, surgical instruments, joint replacement implants and intraocular lenses. 

A major development in 2026 was the FDA's De Novo authorisation of OTTAVA, its table-integrated soft tissue robotic surgical system. Designed for multiple general surgery procedures, the platform marks J&J's entry into a competitive surgical robotics market.

The company also advanced its cardiovascular portfolio with the European launch of VARIPULSE Pro, a next-generation pulsed field ablation system.

MedTech generated US$33.79bn in revenue in 2025, representing 6.1% growth year on year.